Skip to main content

Table 3 Baseline information and the decrease of log10 virus load between Day 0 and Day 2

From: Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study

Patients Characteristics O+P group O group P value
All patients n = 39 n = 43  
Patients with both day 0 and day 2 available specimens n = 31 n = 29  
  Age (years): mean (SD) 55.45(14.80) 60.79(14.62) 0.94
  No. of male (%) 22(56.41) 22(51.16) 0.45
  Time from symptom onset to NAIs administration (days):median(IQR) 7.00(5.00, 8.00) 5.00(4.00, 7.00) 0.46
  APACHE II score: mean(SD) 18.53(8.83) 22.69(8.53) 0.83
  Viral load decrease between day 2 and day 0 (log10 /ul): median(IQR) 0.69(0.31, 1.56) 0.00(−0.59, 1.18) 0.06
  1. O oseltamivir monotherapy, O+P oseltamivir-peramivir combination therapy, IQR interquartile range, percentile 25 – percentile75